LRRK2 and Parkinson disease: As the G2019S mutation, the most frequent pathogenic mutation, substantially increases the LRRK2 kinase activity [18], it has been proposed that an abnormal increase in the phosphorylation of LRRK2 substrates causes neurodegeneration in PD.